Quick Comparison

Citicoline (CDP-Choline)Methylene Blue
Half-Life56-71 hours (sustained release characteristics)5-6 hours
Typical DosageStandard: 250-500 mg daily. Clinical studies use 500-2000 mg daily. Take in the morning — mildly stimulating. Cognizin is the most studied form. Can be split into 2 doses. Often combined with racetams to provide the choline needed for enhanced acetylcholine turnover.Nootropic dose: 0.5-2 mg/kg body weight (typically 30-60 mg for most adults). Pharmaceutical grade USP only — never use industrial or aquarium-grade. Start at the lowest dose. Turns urine blue/green (harmless).
AdministrationOral (capsules, powder). Cognizin branded form is most studied. Take in the morning.Oral (solution, capsules). Must be pharmaceutical/USP grade. Sublingual for faster absorption.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Citicoline (CDP-Choline)

Citicoline (CDP-choline) is hydrolyzed in the gut by alkaline phosphatase to choline and cytidine-5'-monophosphate, which are absorbed separately and reassembled in the brain via the Kennedy pathway. Choline feeds two critical pathways: (1) Acetylcholine synthesis via choline acetyltransferase (ChAT) — the primary memory and learning neurotransmitter acting at muscarinic and nicotinic receptors. (2) Phosphatidylcholine synthesis via CTP:phosphocholine cytidylyltransferase — the structural component of neuronal membranes and synaptic vesicles. Cytidine is dephosphorylated to uridine, converted to UTP, and supports RNA synthesis and CDP-choline formation for synapse formation. Citicoline also activates SIRT1 (possibly via NAD+ modulation) and increases brain norepinephrine and dopamine (mechanism unclear — may enhance synthesis or release). It is the only choline source providing both cholinergic and membrane-building support in one molecule.

Methylene Blue

Methylene blue has a unique property: it acts as an alternative electron carrier in the mitochondrial electron transport chain, cycling between oxidized (blue) and reduced (leuco) forms. It can accept electrons from Complex I (NADH) and donate them directly to cytochrome c, bypassing dysfunctional Complex II and III—maintaining ATP production when mitochondria are damaged or in hypoxic conditions. Methylene blue inhibits nitric oxide synthase (NOS), reducing NO production and the formation of peroxynitrite (ONOO-), a potent oxidant that damages mitochondria. It acts as a redox cycler with antioxidant properties and may enhance cytochrome c oxidase (Complex IV) activity. At low doses, it inhibits tau protein aggregation and tau-tau interactions (relevant to Alzheimer's pathology) and may improve mitochondrial respiration through multiple mechanisms.

Risks & Safety

Citicoline (CDP-Choline)

Common

Headache (especially with racetams — indicates too much cholinergic stimulation), nausea, diarrhea.

Serious

None documented at standard doses.

Rare

Insomnia, blurred vision.

Methylene Blue

Common

Blue/green discoloration of urine and potentially skin at higher doses, nausea, headache.

Serious

Serotonin syndrome risk when combined with SSRIs, SNRIs, or MAOIs — DO NOT combine. Contraindicated in G6PD deficiency (can cause hemolytic anemia).

Rare

Confusion, shortness of breath, chest pain.

Full Profiles